Skip to main content
CPC 2023 Main banner

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Friday, October 6, 2023
  • 8:00 AM – 9:00 AM ET
    Breakfast Networking Session with Complimentary Headshot Session
    Socialize with fellow attendees over breakfast to kick off the event. Complimentary headshots from a professional photographer to update your professional profile will be available.
  • 9:00 AM – 9:15 AM ET
    Journal of Clinical Pathways: Best of 2023 Presentation

    Presenter: Winston Wong, PharmD – W-Squared Group

    The Editor-in-Chief of the Journal of Clinical Pathways (JCP) Winston Wong, PharmD will review the Journal’s most important articles from the past year. JCP features peer-reviewed education on the development, implementation, and evaluation of clinical pathways. Relevant topics include comparative-effectiveness research; big data analytics; methods in clinical pathway development; optimization of clinical pathway implementation and adherence; health economics and outcomes research; patient-centered outcomes; and alternative payment and value-based care models.
  • 9:25 AM – 9:30 AM ET
    Welcome Remarks
  • 9:30 AM – 10:05 AM ET
    Session 1: CPC + CBEx: A New Agenda in Oncology

    Moderator: Gordon Kuntz – Kuntz Consulting

    Panelist: Ronald Barkley, MS, JD – Cancer Center Business Development Group

    Panelist: Lee Blansett, MBA, BSC – HMP Market Access

    Panelist: Stephen B. Edge, MD, FACS, FASCO – Roswell Park Comprehensive Cancer Center

    Panelist: John E. Hennessy, MBA – Valuate Health Consultancy

    Panelist: Deirdre Saulet, PhD – Carrum Health

    Panelist: Mahek A. Shah, MD, MBA, MS – Harvard University and WTM Advisors

    Bringing together the best of pathways and oncology business expertise. Lee Blansett will present critical trends from the IDN, Community Oncology, Payer and Pathways Reports that are driving the current oncology marketplace. Following his presentation, a panel of pathways and oncology business leaders will highlight their key takeaways and discuss where we will dive deeper throughout the event.
  • 10:05 AM – 10:45 AM ET
    Session 2: Updates from Washington

    Moderator: Barbara McAneny, MD – New Mexico Oncology Hematology Consultants & Former President AMA

    Panelist: Nicolas Ferreyros – Community Oncology Alliance (COA)

    Panelist: Frederick M. Schnell, MD, FACP – National Cancer Treatment Alliance/Community Oncology Alliance

    Review the latest developments from Capitol Hill and HHS and show how recent changes will affect community oncology practice.
  • 10:45 AM – 11:45 AM ET
    Session 3: Treating the Individual

    Moderator: Mahek A. Shah, MD, MBA, MS – Harvard University and WTM Advisors

    Panelist: Mary E. Cooley, PhD, RN, FAAN – Dana-Farber Cancer Institute

    Panelist: David F. Lobach, MD, PhD, MS – Elimu Informatics

    Panelist: Ray Page, DO, PhD, FACOI, FASCO – The Center for Cancer and Blood Disorders

    Dr. Ray Page will discuss the intersection of personalized medicine and treatment pathways and how they can combine to drive the best outcomes in patients. Dr. Mary Cooley and Dr. David Lobach will present their work on a clinical decision-support tools for the management of uncontrolled cancer symptoms.
  • 11:45 AM – 12:30 PM ET
    Session 4: HER2-Positive Breast Cancer: Establishing Proper Sequences Through Clinical Pathways

    Moderator: Stephen B. Edge, MD, FACS, FASCO – Roswell Park Comprehensive Cancer Center

    Presenter: Sayeh Lavasani, MD, MS, FRCPC – UC Irvine Cancer Center

    After completing this activity, learners will be able to • Assess efficacy and safety of current and recently approved agents to incorporate into second- and third-line treatment of HER2-positive breast cancer • Describe the challenges of creating and implementing clinical pathways for HER2-positive breast cancer • Develop clinical pathways for HER2-positive breast cancer to optimize evidence-based and cost effective second- and third- line treatments
  • 12:40 PM – 1:40 PM ET
    Non-Accredited Featured Partner Showcase

    Moderator: Rushir Choksi, MD – UPMC Hillman Cancer Center

    Presenter: Ed Rodgers – ClinicalPath

    Presenter: Joe Baffone – Annexus Health

    Presenter: Susan Weidner – IntrinsiQ

  • 1:50 PM – 2:20 PM ET
    Session 5: Time to Treat: Why it Matters and How Pathways Can Help

    Moderator: Mahek A. Shah, MD, MBA, MS – Harvard University and WTM Advisors

    Presenter: Dennis R. Holmes, MD, FACS – XpediteMD, Inc.

    Dr. Dennis Holmes will connect delays between diagnosis and treatment to their effects on patient outcomes. Then he will explore ways to close the diagnosis-treatment gap, including effective use of pathways.
  • 2:20 PM – 3:50 PM ET
    Session 6: The Hunt for Value in Value-Based Cancer Care: How to Meet Stakeholders' Evolving Demands

    Moderator: Deirdre Saulet, PhD – Carrum Health

    Panelist: Afsaneh Barzi, MD, PhD – AccessHope

    Panelist: Ronda Bowman, MHA, RN, OCN – ASCO Care Delivery

    Panelist: David Eagleton – Oncology Care Partners

    Panelist: Andrew Hertler, MD, FACP – Evolent

    Panelist: Harlan Levine, MD – City of Hope

    Panelist: Barry Russo, MBA – The Center for Cancer and Blood Disorders

    Panelist: Stephen Schleicher, MD, MBA – Tennessee Oncology

    Panelist: Frederick M. Schnell, MD, FACP – National Cancer Treatment Alliance/Community Oncology Alliance

    Our keynote opening will provide insights into today’s top market dynamics impacting cancer care and the key trends to keep your eye on in the future. • Learn why self-insured employers are increasingly focused on improving their cancer care benefits and the impact on other stakeholders across the industry • Understand the complexities of the Medicare Advantage market and what its growth means for practice leaders and physicians leading the way, and their motivations
  • 3:50 PM – 4:00 PM ET
    Break
  • 4:00 PM – 5:00 PM ET
    Session 7: Healthcare Industry Consolidation: The Impact on Cancer Care and Strategic Partnerships

    Moderator: Michael Kolodziej, MD – ADVI

    Panelist: Ronald Barkley, MS, JD – Cancer Center Business Development Group

    Panelist: Harlan Levine, MD – City of Hope

    Panelist: Barbara McAneny, MD – New Mexico Oncology Hematology Consultants & Former President AMA

    Panelist: Todd Schonherz – American Oncology Network

    Panelist: Adria Warren, JD – Foley & Lardner

    • Overview of the current consolidation of the healthcare industry, the major players and disruptors leading the way, and their motivations • Learn how leading providers are developing strategies to respond, including affiliation models
  • 5:00 PM – 6:00 PM ET
    Exhibit Hall